BERKELEY HEIGHTS, N.J., Jan. 11, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”) today summarized its 2011 achievements and set forth the Company’s key business objectives for 2012 in a presentation given by Spiro Rombotis, President and Chief Executive Officer, at the 5th Annual OneMedForum Conference held this week in San Francisco, California.
